FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $634,836 | +34.1% | 142,981 | -0.3% | 0.00% | – |
Q2 2023 | $473,309 | -63.3% | 143,427 | -68.3% | 0.00% | – |
Q1 2023 | $1,288,063 | -54.7% | 451,952 | +15.7% | 0.00% | -100.0% |
Q4 2022 | $2,842,665 | +12.9% | 390,476 | +25.4% | 0.00% | 0.0% |
Q3 2022 | $2,518,000 | +66.8% | 311,293 | +1.0% | 0.00% | – |
Q2 2022 | $1,510,000 | -75.1% | 308,294 | +20.0% | 0.00% | -100.0% |
Q1 2022 | $6,076,000 | +30.6% | 256,926 | -2.3% | 0.00% | 0.0% |
Q4 2021 | $4,654,000 | -36.0% | 263,073 | +2.0% | 0.00% | 0.0% |
Q3 2021 | $7,275,000 | +218.8% | 257,872 | +18.4% | 0.00% | – |
Q2 2021 | $2,282,000 | -1.8% | 217,711 | +10.4% | 0.00% | – |
Q1 2021 | $2,323,000 | +4.4% | 197,208 | +3.8% | 0.00% | – |
Q4 2020 | $2,225,000 | +57.5% | 190,009 | +6.6% | 0.00% | – |
Q3 2020 | $1,413,000 | -53.9% | 178,169 | +6.4% | 0.00% | -100.0% |
Q2 2020 | $3,063,000 | +91.1% | 167,473 | +24.7% | 0.00% | – |
Q1 2020 | $1,603,000 | +88.8% | 134,285 | +163.0% | 0.00% | – |
Q4 2019 | $849,000 | +140.5% | 51,052 | -4.1% | 0.00% | – |
Q3 2019 | $353,000 | – | 53,211 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,962,202 | $32,054,000 | 14.00% |
TRV GP IV, LLC | 2,343,154 | $18,956,000 | 11.08% |
Logos Global Management LP | 1,950,000 | $15,776,000 | 1.94% |
COWEN AND COMPANY, LLC | 2,347,989 | $18,995,000 | 1.82% |
VR Adviser, LLC | 1,200,000 | $9,708,000 | 1.50% |
RA Capital Management | 7,000,000 | $56,630,000 | 1.21% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,528,000 | $28,542,000 | 1.18% |
ACUTA CAPITAL PARTNERS, LLC | 220,000 | $1,780,000 | 0.77% |
RTW INVESTMENTS, LP | 3,985,910 | $32,246,000 | 0.74% |
BRANDYWINE MANAGERS, LLC | 26,127 | $211,000 | 0.69% |